The Resilience Clinic Evaluation

The Resilience Clinic: Program Evaluation and Quality Improvement

Early life adversity can affect children's physical and mental health. The Resilience Clinic is a support program for young children and their caregivers who have been exposed to significant adversity, aiming to prevent the harmful effects of stress and improve child health, behavior, and development while also reducing caregiver stress. This study seeks to evaluate the Resilience Clinic, assessing the intervention's impact on child health, behavior, and development and caregiver stress and mental health.

Study Overview

Detailed Description

Early-life trauma and related adversities are prevalent and associated with negative health, developmental, and behavioral outcomes in children. Research to design and test practical, scalable healthcare interventions that mitigate toxic stress is needed to promote improved health and developmental outcomes in children.

The Resilience Clinic is an interactive, caregiver-child psychoeducational intervention for parents and other adult caregivers of young children (ages 0-5 years) with exposure to traumatic events or other significant adversity. The aim of this primary-care based intervention is to prevent or mitigate the toxic stress response, thus promoting child resilience in the face of adversity, with the goal of improving child health, behavioral, and developmental outcomes.

The overall aim of this study is to evaluate the the efficacy and operational feasibility of the revised Resilience Clinic (RC). This is a non-randomized clinical trial comparing intervention caregiver-child dyads to a prospective control group drawn from a concurrent clinical trial (NCT05259436, The Collaborative Approach to Examining Adversity and Building Resilience Study (CARE), PI Thakur). In the intervention group, we will conduct pre-post intervention comparisons along with comparisons between the intervention group and the control group drawn from the CARE study. A subgroup analysis will compare two intervention arms (clinic based vs community-based intervention) to each other and the control condition. This clinical trial is supplemented by a mixed-methods quality improvement (QI) tools, including process measures (attendance and billing/claims data) to evaluate operational and financial feasibility; participant surveys/interviews/focus groups to assess acceptability; and analysis of quality improvement meeting notes.

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • California
      • Oakland, California, United States, 94609
        • Recruiting
        • UCSF Benioff Children's Hospital Oakland
        • Contact:
        • Contact:
      • Oakland, California, United States, 94601
        • Not yet recruiting
        • La Clinica de la Raza
        • Contact:
      • Oakland, California, United States, 94607
        • Not yet recruiting
        • Asian Health Services
        • Contact:
      • San Leandro, California, United States, 94577
        • Not yet recruiting
        • UBCP-Bancroft Pediatrics
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 years to 5 years (Child)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Caregiver: 18 years old and older, primary caregiver, English or Spanish speaking
  • Child: 2 to 5 years, PEARLS score > 1 or verbal disclosure of PEARLS adversity to primary care clinician/staff

Exclusion Criteria:

  • Caregiver: active suicidality, other psychiatric issues
  • Child: significant medical co-morbidities (i.e. disease requiring immunomodulators, chemo or radiation therapy, or hormonal therapy)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Resilience Clinic
A psychoeducational caregiver-child intervention based in primary care, designed to mitigate toxic stress and promote child resilience. Participants engage in 6 weekly visits in primary care using an interactive curriculum based in the evidence-based Circle of Security Parenting along with mindfulness principles.
Active Comparator: Control
Enhanced pediatric primary care
In addition to usual pediatric primary care, enhanced primary care (the control condition for this study) provides navigational services to link to community resources based on screening for unmet social needs (e.g., food insecurity, housing, financial strain).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Parenting Stress Index Short Form (PSI) score
Time Frame: baseline/enrollment and 2 week and 3-month follow-up after intervention ends
36-item caregiver-report questionnaire validated as a measure of parenting stress (level of stress within the context of parenting). Responses indicated on a 5-point Likert scale. Higher scores indicate higher levels of parenting stress.
baseline/enrollment and 2 week and 3-month follow-up after intervention ends
Change in Child Behavior Checklist (CBCL)-Preschool form total problems scale score
Time Frame: baseline/enrollment and 2 week and 3-month follow-up after intervention ends
Caregiver-report questionnaire validated as a measure of child behavioral challenges; part of the Achenbach System of Empirically Based Assessment (ASEBA). The CBCL-Preschool form is validated for children ages 1.5-5 years based on behavior from the prior 2 months.
baseline/enrollment and 2 week and 3-month follow-up after intervention ends

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Behavior Rating Inventory of Executive Function, Preschool Version (BRIEF-P) score
Time Frame: baseline/enrollment and 2 week and 3-month follow-up after intervention ends
Caregiver-report questionnaire, validated as a measure of executive functioning in preschool aged children (ages 2-5:11)
baseline/enrollment and 2 week and 3-month follow-up after intervention ends
Change in Patient-Reported Outcomes Measurement Information System (PROMIS) global health score
Time Frame: baseline/enrollment and 2 week and 3-month follow-up after intervention ends
PROMIS is a set of person-centered measure evaluating the physical, mental, and social health of adults and children. This study uses the first question on the global scale, with a minimum value of 1 and maximum of 5; higher scores indicate better general health.
baseline/enrollment and 2 week and 3-month follow-up after intervention ends
Change in Ages and Stages Questionnaire (ASQ)-3rd Edition scores
Time Frame: baseline/enrollment to 3 month follow-up after intervention ends
Caregiver-report questionnaire validated as a measure for risk of developmental delay in children ages 0-60 months.
baseline/enrollment to 3 month follow-up after intervention ends
Change in Caregiver depression score on the Patient Health Questionnaire (PHQ)-8 scale
Time Frame: baseline/enrollment and 2 week and 3-month follow-up after intervention ends
Questionnaire validated as a measure of depressive symptoms; higher scores indicate higher self-report depressive symptoms. Will be given to questionnaires to assess their depressive symptoms.
baseline/enrollment and 2 week and 3-month follow-up after intervention ends
Change in Caregiver anxiety score on the Generalized Anxiety Disorder (GAD) scale
Time Frame: baseline/enrollment and 2 week and 3-month follow-up after intervention ends
Questionnaire validated as a measure of anxiety symptoms; high scores indicate higher levels of anxiety. Will be given to caregivers to assess their anxiety symptoms.
baseline/enrollment and 2 week and 3-month follow-up after intervention ends
Change in Perceived Stress Scale (PSS) total score- Caregiver general stress
Time Frame: baseline/enrollment and 2 week and 3-month follow-up after intervention ends
Self-report questionnaire that measures global perceived stress based on feelings and thoughts during the last month. Higher scores indicate higher perceived stress. Will be given to caregivers as a measure of their general perceived stress.
baseline/enrollment and 2 week and 3-month follow-up after intervention ends
Change in telomere length (children)
Time Frame: baseline/enrollment to 3 month follow-up after intervention ends
Telomere are nucleoproteins that protect the ends of chromosomes and can be used as a biomarker of cellular aging. Chronic stress has been associated with shorter telomere length. DNA will be extracted from cheek cells (obtained by buccal swab) in children.
baseline/enrollment to 3 month follow-up after intervention ends

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 25, 2023

Primary Completion (Estimated)

November 30, 2023

Study Completion (Estimated)

November 30, 2023

Study Registration Dates

First Submitted

December 29, 2022

First Submitted That Met QC Criteria

January 9, 2023

First Posted (Actual)

January 19, 2023

Study Record Updates

Last Update Posted (Actual)

May 31, 2023

Last Update Submitted That Met QC Criteria

May 26, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 22-37781

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Early Life Adversity

Clinical Trials on Resilience Clinic

3
Subscribe